Evidence map›Paper›PMID 35607895›Full record

ArticleeLife2022

Association of egg consumption, metabolic markers, and risk of cardiovascular diseases: A nested case-control study.

Lang Pan, Lu Chen, Jun Lv, Yuanjie Pang, Yu Guo, Pei Pei, Huaidong Du, Ling Yang, Iona Y Millwood, Robin G Walters and 7 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Influencing Factors on Cardiovascular Health in China.Journal of geriatric cardiology : JGC · 2024
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Lang PanDepartment of Epidemiology and Biostatistics, Peking University, Beijing, China.ORCID 0000-0002-5231-367X
Lu ChenDepartment of Epidemiology and Biostatistics, Peking University, Beijing, China.
Jun LvDepartment of Epidemiology and Biostatistics, Peking University, Beijing, China.ORCID 0000-0001-7916-3870
Yuanjie PangDepartment of Epidemiology and Biostatistics, Peking University, Beijing, China.ORCID 0000-0002-4826-8861
Yu GuoFuwai Hospital Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing, China.
Pei PeiChinese Academy of Medical Sciences, Beijing, China.
Huaidong DuMedical Research Council Population Health Research Unit at the University of Oxford, Oxford, United Kingdom.
Ling YangMedical Research Council Population Health Research Unit at the University of Oxford, Oxford, United Kingdom.
Iona Y MillwoodMedical Research Council Population Health Research Unit at the University of Oxford, Oxford, United Kingdom.
Robin G WaltersMedical Research Council Population Health Research Unit at the University of Oxford, Oxford, United Kingdom.
Yiping ChenMedical Research Council Population Health Research Unit at the University of Oxford, Oxford, United Kingdom.
Weiwei GongNCDs Prevention and Control Department, Zhejiang CDC, Hangzhou, China.
Junshi ChenChina National Center for Food Safety Risk Assessment, Beijing, China.
Canqing YuDepartment of Epidemiology and Biostatistics, Peking University, Beijing, China.ORCID 0000-0002-0019-0014
Zhengming ChenClinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Liming LiDepartment of Epidemiology and Biostatistics, Peking University, Beijing, China.
China Kadoorie Biobank Collaborative Group
Peking University · CNUniversity of Oxford · GBAcademy of Medical Sciences · GBChina National Center for Food Safety Risk Assessment · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNZhejiang Center for Disease Control and Prevention · CN

Funding

Cancer Research UK 29186Medical Research Council MC_U137686851Medical Research Council MC_UU_00017/1Medical Research Council MC_UU_12026/2Wellcome Trust 212946/Z/18/Z
6 · The paper itself

Abstract

Background: Few studies have assessed the role of individual plasma cholesterol levels in the association between egg consumption and the risk of cardiovascular diseases. This research aims to simultaneously explore the associations of self-reported egg consumption with plasma metabolic markers and these markers with the risk of cardiovascular disease (CVD). Methods: Totally 4778 participants (3401 CVD cases subdivided into subtypes and 1377 controls) aged 30-79 were selected based on the China Kadoorie Biobank. Targeted nuclear magnetic resonance was used to quantify 225 metabolites in baseline plasma samples. Linear regression was conducted to assess associations between self-reported egg consumption and metabolic markers, which were further compared with associations between metabolic markers and CVD risk. Results: Egg consumption was associated with 24 out of 225 markers, including positive associations for apolipoprotein A1, acetate, mean HDL diameter, and lipid profiles of very large and large HDL, and inverse associations for total cholesterol and cholesterol esters in small VLDL. Among these 24 markers, 14 were associated with CVD risk. In general, the associations of egg consumption with metabolic markers and of these markers with CVD risk showed opposite patterns. Conclusions: In the Chinese population, egg consumption is associated with several metabolic markers, which may partially explain the protective effect of moderate egg consumption on CVD. Funding: This work was supported by the National Natural Science Foundation of China (81973125, 81941018, 91846303, 91843302). The CKB baseline survey and the first re-survey were supported by a grant from the Kadoorie Charitable Foundation in Hong Kong. The long-term follow-up is supported by grants (2016YFC0900500, 2016YFC0900501, 2016YFC0900504, 2016YFC1303904) from the National Key R&D Program of China, National Natural Science Foundation of China (81390540, 81390541, 81390544), and Chinese Ministry of Science and Technology (2011BAI09B01). The funders had no role in the study design, data collection, data analysis and interpretation, writing of the report, or the decision to submit the article for publication.

Indexed as

Cardiovascular DiseasesApolipoprotein A-IBiomarkersCase-Control StudiesChinaCholesterolHumansRisk FactorsApolipoprotein A-IBiomarkersCholesterolbiochemistrycardiovascular diseaseschemical biologyegg consumptionepidemiologyglobal healthhumanlipoproteinsmetabolomics

Identifiers

PMID35607895
PMCPMC9129873
OpenAlexW4281391906

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.